231 related articles for article (PubMed ID: 26614640)
1. CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.
Butcher MJ; Wu CI; Waseem T; Galkina EV
Int Immunol; 2016 May; 28(5):255-61. PubMed ID: 26614640
[TBL] [Abstract][Full Text] [Related]
2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
3. The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.
Butcher MJ; Gjurich BN; Phillips T; Galkina EV
Circ Res; 2012 Mar; 110(5):675-87. PubMed ID: 22302786
[TBL] [Abstract][Full Text] [Related]
4. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
Smith E; Prasad KM; Butcher M; Dobrian A; Kolls JK; Ley K; Galkina E
Circulation; 2010 Apr; 121(15):1746-55. PubMed ID: 20368519
[TBL] [Abstract][Full Text] [Related]
5. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall.
Galkina E; Harry BL; Ludwig A; Liehn EA; Sanders JM; Bruce A; Weber C; Ley K
Circulation; 2007 Oct; 116(16):1801-11. PubMed ID: 17909108
[TBL] [Abstract][Full Text] [Related]
6. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
7. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
10. The Two Faces of Interleukin-17A in Atherosclerosis.
Akhavanpoor M; Akhavanpoor H; Gleissner CA; Wangler S; Doesch AO; Katus HA; Erbel C
Curr Drug Targets; 2017; 18(7):863-873. PubMed ID: 28034277
[TBL] [Abstract][Full Text] [Related]
11. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
[TBL] [Abstract][Full Text] [Related]
12. Identification of heterogeneous subsets of aortic interleukin-17A-expressing CD4
Lin G; Zhang L; Yan Z; Jiang W; Wu B; Li D; Xiong X
Int J Immunopathol Pharmacol; 2022; 36():3946320221117933. PubMed ID: 35932160
[TBL] [Abstract][Full Text] [Related]
13. IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis.
Engelbertsen D; Rattik S; Wigren M; Vallejo J; Marinkovic G; Schiopu A; Björkbacka H; Nilsson J; Bengtsson E
Cardiovasc Res; 2018 Jan; 114(1):180-187. PubMed ID: 29036304
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen-induced arthritis by the chemokine receptor CXCR6.
Slauenwhite D; Gebremeskel S; Doucette CD; Hoskin DW; Johnston B
Arthritis Rheumatol; 2014 Nov; 66(11):3001-12. PubMed ID: 25132679
[TBL] [Abstract][Full Text] [Related]
15. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
Jeon US; Choi JP; Kim YS; Ryu SH; Kim YK
Exp Mol Med; 2015 May; 47(5):e163. PubMed ID: 25976521
[TBL] [Abstract][Full Text] [Related]
16. IL-22 produced by Th22 cells aggravates atherosclerosis development in ApoE
Shi L; Ji Q; Liu L; Shi Y; Lu Z; Ye J; Zeng T; Xue Y; Yang Z; Liu Y; Lu J; Huang X; Qin Q; Li T; Lin YZ
J Cell Mol Med; 2020 Mar; 24(5):3064-3078. PubMed ID: 32022386
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K
Circ Res; 2012 Oct; 111(10):1274-85. PubMed ID: 22927332
[TBL] [Abstract][Full Text] [Related]
18. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.
Ge S; Hertel B; Koltsova EK; Sörensen-Zender I; Kielstein JT; Ley K; Haller H; von Vietinghoff S
Circ Res; 2013 Sep; 113(8):965-74. PubMed ID: 23908345
[TBL] [Abstract][Full Text] [Related]
19. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
[TBL] [Abstract][Full Text] [Related]
20. Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis.
Cai Y; Kobayashi R; Hashizume-Takizawa T; Kurita-Ochiai T
Arch Oral Biol; 2014 Nov; 59(11):1183-91. PubMed ID: 25103543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
